IPV Type-Two Polio Seroconversion Rates by Age and Dose Schedule, 1985-2022

Binomial regression model results for IPV-induced type-two polio seroconversion across different ages and dosing schedules. The model was fitted to a review of 19 seroconversion studies conducted between 1985 and 2022. The dataset was authored by Elizabeth J. Gray and published on figshare.

Use Cases

• Modeling vaccine seroconversion rates based on age of administration.
• Comparing immunogenicity outcomes based on different dose schedules.
• Estimating population immunity levels for polio serotype 2.
• Evaluating the impact of earlier versus later vaccination schedules.

Strengths

• Model based on 19 seroconversion studies.
• Data spans studies from 1985 to 2022.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Elizabeth J. Gray via figshare.

Collection Method

Fitting a binomial regression model to a review of 19 studies.

Time Range

1985-2022

Freshness

Last updated 2026-03-19 17:27:50; freshness should be verified.